Zagazig University Hospitals
Zagazig, Egypt
NCT Number: NCT06524011
in a split face fashion, 30 patients will be randomized into 3 groups: Group A: rt side treated with SVF enriched PRP, lt side treated with prp Group B: rt side treated with SVF enriched PRP, lt side treated with SVF Group C: rt side treated with PRP, lt side treated with SVF
Trial opening soon.
Get Notified18 year–40 year
All sexes
Interventional
Not applicable
Zagazig, Egypt
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adipose derived stromal vascular fraction cells will be aspirated and isolated from patient autologous adipose tissue and used to enrich patient's autologous platelet rich plasma then will be used to treat atrophic post acne scars versus each alone.
Time frame: 3 monthly sessions and follow up for 3 months after the last visit
at baseline, acne scars will be assessed clinically using the 4 point grading system proposed by Goodman &colleagues in 2006, patients' complaints and expectations will be addressed as well and the impact of acne scars on patients' quality of life will be investigated using the dermatology life quality index (DLQI). Goodman scoring system will be used at the last session and at the follow up visit to measure the change pre and post treatment.
Zagazig University
Other Gov
Split Face Comparative Study of Stromal Vascular Fraction Enriched PRP Versus Each Alone in Treatment of Atrophic Post-acne Scars
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07620769
Acne Scar, Acne Scarring
Chengdu, China
View Trial DetailsNCT07471854
Acne Scars - Atrophic
View Trial DetailsNCT07094958
Acne Scars, Acne Scars - Atrophic
View Trial DetailsNCT07305675
Acne Scars - Atrophic, Wound Healing
Xi'an, Shaanxi, China
View Trial Details